Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)

NCT00781573 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

167

Enrollment

FED

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Clopidogrel

Sponsor

North Texas Veterans Healthcare System